Acadian Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-155,070
| Closed | -$505K | – | 2063 |
|
|
2022
Q4 | $505K | Hold |
155,070
| – | – | ﹤0.01% | 1030 |
|
|
2022
Q3 | $455K | Hold |
155,070
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q2 | $382K | Buy |
155,070
+56,223
| +57% | +$139K | ﹤0.01% | 1050 |
|
|
2022
Q1 | $797K | Buy |
98,847
+6,010
| +6% | +$48.5K | ﹤0.01% | 880 |
|
|
2021
Q4 | $1.23M | Buy |
92,837
+85,041
| +1,091% | +$1.13M | ﹤0.01% | 779 |
|
|
2021
Q3 | $339K | Buy |
7,796
+5,769
| +285% | +$251K | ﹤0.01% | 1157 |
|
|
2021
Q2 | $85K | Buy |
+2,027
| New | +$85K | ﹤0.01% | 1676 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | – | – | 2402 |
|
|
2020
Q3 | $0 | Sell |
3
-490
| -99% | – | ﹤0.01% | 2436 |
|
|
2020
Q2 | $52K | Buy |
493
+490
| +16,333% | +$51.7K | ﹤0.01% | 1909 |
|
|
2020
Q1 | $0 | Sell |
3
-1,273
| -100% | – | ﹤0.01% | 1996 |
|
|
2019
Q4 | $145K | Sell |
1,276
-941
| -42% | -$107K | ﹤0.01% | 1366 |
|
|
2019
Q3 | $137K | Sell |
2,217
-1,845
| -45% | -$114K | ﹤0.01% | 1405 |
|
|
2019
Q2 | $317K | Buy |
4,062
+1,206
| +42% | +$94.1K | ﹤0.01% | 1122 |
|
|
2019
Q1 | $385K | Buy |
2,856
+2,259
| +378% | +$305K | ﹤0.01% | 1181 |
|
|
2018
Q4 | $48K | Sell |
597
-1,817
| -75% | -$146K | ﹤0.01% | 1433 |
|
|
2018
Q3 | $253K | Buy |
2,414
+333
| +16% | +$34.9K | ﹤0.01% | 1035 |
|
|
2018
Q2 | $208K | Sell |
2,081
-1,571
| -43% | -$157K | ﹤0.01% | 1077 |
|
|
2018
Q1 | $460K | Buy |
3,652
+2,568
| +237% | +$323K | ﹤0.01% | 882 |
|
|
2017
Q4 | $181K | Buy |
1,084
+1,005
| +1,272% | +$168K | ﹤0.01% | 977 |
|
|
2017
Q3 | $25K | Sell |
79
-11,619
| -99% | -$3.68M | ﹤0.01% | 1190 |
|
|
2017
Q2 | $3.47M | Buy |
11,698
+10,047
| +609% | +$2.98M | 0.02% | 459 |
|
|
2017
Q1 | $381K | Buy |
+1,651
| New | +$381K | ﹤0.01% | 944 |
|